ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Total joint replacement"

  • Abstract Number: 1642 • ACR Convergence 2022

    Mast Cells May Explain Sex Differences in Osteoarthritis Pain

    Bella Mehta1, Edward DiCarlo2, Fei Wang3, Miguel Otero4, Eun Kyung Song5, Peter Sculco2, Mark Figgie2, Susan Goodman2, William Robinson5 and Dana Orange6, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Weil Cornell Medical College, New York, NY, 4Hospital for Special Surgery Research Institute, New York, NY, 5Stanford University School of Medicine, Palo Alto, CA, 6The Rockefeller University, New York, NY

    Background/Purpose: Women are at increased risk for knee osteoarthritis(OA) and report more severe pain than men at the time of total knee arthroplasty. It has…
  • Abstract Number: 1905 • ACR Convergence 2022

    Does Exercise Before Surgery Predict Trajectories of Physical Activity After Knee Replacement?

    Jéssica Bianca Aily1, Dana Voinier1, Jason Jakiela1, Thomas Bye1, Hiral Master1, Louise Thoma2 and Daniel White1, 1University of Delaware, Newark, DE, 2UNC School of Medicine, Chapel Hill, NC

    Background/Purpose: Total knee replacement (TKR) is the definitive treatment for adults with knee osteoarthritis (OA) and is often successful in reducing pain and improving function.…
  • Abstract Number: 1920 • ACR Convergence 2022

    Gait and Physical Activity Predictors of Knee Replacement: A Machine Learning Analysis in the Multicenter Osteoarthritis Study

    Kerry Costello1, David Felson1, S. Reza Jafarzadeh2, Neil Segal3, Cora E. Lewis4, Michael Nevitt5, Vijaya Kolachalama2 and Deepak Kumar1, 1Boston University, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3University of Kansas, Kansas City, KS, 4University of Alabama at Birmingham, Birmingham, AL, 5University of California at San Francisco, Orinda, CA

    Background/Purpose: Rates of knee replacement (KR) due to knee osteoarthritis (OA) are rising exponentially and currently no interventions prevent KR. Gait and physical activity are…
  • Abstract Number: 2087 • ACR Convergence 2022

    Prospective Study of Clinical, Laboratory, and Patient-Reported Outcomes of Patients with Systemic Lupus Erythematosus Undergoing Total Hip and Total Knee Arthroplasty

    David Fernandez, Insa Mannstadt, Mark Figgie, Peter Sculco, Jason Blevins, Caroline Siegel, Deanna Jannat-Khah, DrPH, MSPH, Carey Ford, Mikhail Olferiev, Dina Greenman, Kyriakos Kirou and Susan Goodman, Hospital for Special Surgery, New York, NY

    Background/Purpose: Patients with SLE have doubled their utilization of THA and TKA, yet postoperative complications remain high. However, disease specific measures have not been assessed.…
  • Abstract Number: 0552 • ACR Convergence 2022

    Identifying Subgroups of Patients Undergoing Knee Replacement

    Brooke McGinley1, Gabriela Rabasa2, Tuhina Neogi3, David Felson2 and Michael LaValley4, 1Boston University School of Public Health, Boston, MA, 2Boston University, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Boston University School of Public Health, Arlington, MA

    Background/Purpose: Knee replacement surgery (KR) is prevalent in the US with estimated lifetime risk from age 25 of 7% for males and 9.5% for females,…
  • Abstract Number: 0837 • ACR Convergence 2022

    Providers’ Adoption of 2017 Guidelines on DMARD Use Perioperatively for Elective Total Hip and Knee Arthroplasty at a Single Academic Center

    Chris Ching1, Erica Mulcaire-Jones2, Andrew Shaffer1, Jeremy Gililland1, Michael Battistone3 and Dorota Lebiedz-Odrobina1, 1University of Utah, Salt Lake City, UT, 2Intermountain Healthcare, Salt Lake City, UT, 3Salt Lake City VA, Salt Lake City, UT

    Background/Purpose: Rate of prosthetic joint infection (PJI) after total joint arthroplasty (TJA) is higher in patients with rheumatic conditions than in patients with OA. Our…
  • Abstract Number: 0845 • ACR Convergence 2022

    Predictors of Moderate-Vigorous Physical Activity Following a Physical Therapist Led Physical Activity Intervention for Adults with Total Knee Replacement

    Scott Jamieson1 and Christine Pellegrini2, 1The University of South Carolina, Arnold School of Public Health, Department of Exercise Science, Columbia, SC, 2University of South Carolina, Columbia, SC

    Background/Purpose: Following total knee replacement rehabilitation, patients are advised to participate in physical activity. Yet, most individuals at this stage do not increase their physical…
  • Abstract Number: 0654 • ACR Convergence 2021

    Assessing Provider Knowledge and Opinions of the 2017 Guidelines for Perioperative Management of Antirheumatic Medications in a Single Academic Center

    Andrew Shaffer1, Erica Mulcaire-Jones2, Michael Battistone3, Jeremy Gililland4, Victor Carlson4, Joshua Zimmerman4, Kevin Lammert4 and Dorota Lebiedz-Odrobina4, 1University of Utah, Sandy, UT, 2Intermountain Healthcare, Salt Lake City, UT, 3Salt Lake City VA, Salt Lake City, UT, 4University of Utah, Salt Lake City, UT

    Background/Purpose: Guidelines for perioperative management of antirheumatic medications were released by the American College of Rheumatology (ACR) and American Association of Hip and Knee Surgeons…
  • Abstract Number: 0727 • ACR Convergence 2021

    Total Joint Replacements in Three Phase 3 Studies of Tanezumab in Patients with Osteoarthritis

    John Carrino1, Timothy McAlindon2, Eric Vignon3, Mark Brown4, Aimee Burr4, Robert Fountaine4, Glenn Pixton5, Lars Viktrup6, Christine West4 and Kenneth Verburg4, 1Hospital for Special Surgery, New York, NY, 2Tufts Medical Center, Arlington, MA, 3Université Claude Bernard Lyon 1, Lyon, France, 4Pfizer Inc., Groton, CT, 5Pfizer Inc., Morrisville, NC, 6Eli Lilly and Company, Indianapolis, IN

    Background/Purpose: Tanezumab (TNZ) is an antibody against nerve growth factor that has demonstrated efficacy in the management of osteoarthritis (OA). Due to the potential risk…
  • Abstract Number: 0734 • ACR Convergence 2021

    Primary Total Knee Arthroplasty for Knee Osteoarthritis Among Younger versus Older Individuals: Cross-sectional Study of Surgical Appropriateness and Surgeon Decision-Making

    Gillian Hawker1, Eric Bohm2, Michael Dunbar3, Allyson Jones4, Tom Noseworthy5 and Deborah Marshall5, 1University of Toronto, Toronto, ON, Canada, 2Concordia Hip & Knee Institute, Winnipeg, MB, Canada, 3Dalhousie University, Halifax, NS, Canada, 4University of Alberta, Edmonton, AB, Canada, 5University of Calgary, Calgary, AB, Canada

    Background/Purpose: Rising rates of total knee arthroplasty (TKA) in younger adults with knee osteoarthritis (OA) has prompted concern about surgical appropriateness. We compared patient appropriateness…
  • Abstract Number: 0735 • ACR Convergence 2021

    Walking Ability 12 Months After Total Knee Arthroplasty for Osteoarthritis – Gap Between Expectations and Reality: The BEST Knee Cohort Study

    Lauren King, Esther Waugh and Gillian Hawker, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Improved ability to walk is a key driver for people with knee osteoarthritis (OA) to seek total knee arthroplasty (TKA). However, the extent to…
  • Abstract Number: 0736 • ACR Convergence 2021

    Decrease in Prevalence of Self-Reported Anxiety or Depression in Persons with Osteoarthritis After Total Knee Arthroplasty: The BEST KNEE Cohort Study

    Owen Krystia, Lauren King, Esther Waugh and Gillian Hawker, University of Toronto, Toronto, ON, Canada

    Background/Purpose: While anxiety and depression are highly prevalent in persons with symptomatic knee osteoarthritis (OA), few studies have assessed the effect of treatment of knee…
  • Abstract Number: 0755 • ACR Convergence 2021

    Satisfaction with the Process versus Outcome of Care in Total Hip and Knee Arthroplasty

    J. Alex Gibbons1, Cynthia Kahlenberg1, Bella Mehta2, Vinicius Antao1, Emily Ying Lai1, Huong Do1, Linda Russell1, Peter Sculco1, Mark Figgie1 and Susan Goodman1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Patient satisfaction, both with the process of care and the outcome of care, is critical for measuring the quality and value of elective procedures…
  • Abstract Number: 1037 • ACR Convergence 2021

    Variations in Total Knee Replacement Utilization and Outcomes in USA and Canada: The Role of Geography and Socioeconomic Factors

    Bella Mehta1, Kaylee Ho2, Vicki Ling3, Susan Goodman4, Michael Parks4, Bheeshma Ravi5, Samprit Banerjee2, Said Ibrahim6 and Peter Cram7, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 4Hospital for Special Surgery, New York, NY, 5Sunnybrook Research Institute, Toronto, ON, Canada, 6Weill Cornell Medicine, Cleveland, OH, 7Sinai Health System and University Health Network, Toronto, ON, Canada

    Background/Purpose: Total Knee Arthroplasty (TKA) is an effective treatment option for end-stage knee osteoarthritis. The US is well known for having striking wealth-based disparities in…
  • Abstract Number: 1051 • ACR Convergence 2021

    Variance of Joint Space Width Across the Tibiofemoral Joint on Knee Radiographs: A Novel Measure of Structure and Progression

    Kent Kwoh1, Erin Ashbeck2, Edward Bedrick1, Xiaoxiao Sun1 and Jeffrey Duryea3, 1University of Arizona, Tucson, AZ, 2University of Arizona Arthritis Center, Tucson, AZ, 3Brigham and Women's Hospital, Boston, MA

    Background/Purpose: The FDA accepts medial minimum joint space width (mJSW) in the tibiofemoral (TF) compartment as the standard for structural change in clinical trials of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology